Lin Bioscience

Lin Bioscience Debt

The Debt of Lin Bioscience (6696.TWO) as of Oct 10, 2026 is 33.99 M TWD. In the previous year, Debt was 42.87 M TWD — a change of -20.72% (lower).

Debt

33.99 MTWD

YoY

-20.72%

Last updated:

In 2024, Lin Bioscience's total debt was 33.99 M TWD, a -20.72% change from the 42.87 M TWD total debt recorded in the previous year.

The Lin Bioscience Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2017
0.00 TWD
Jan 1, 2018
0.00 TWD
Jan 1, 2019
67.94 M TWD
Jan 1, 2020
5.15 M TWD
Jan 1, 2021
2.24 M TWD
Jan 1, 2022
46.50 M TWD
Jan 1, 2023
42.87 M TWD
Jan 1, 2024
33.99 M TWD
The Lin Bioscience Debt history
YEARDebtYoY
33.99 MTWD-20.72%
42.87 MTWD-7.81%
46.50 MTWD+1,975.10%
2.24 MTWD-56.52%
5.15 MTWD-92.41%
67.94 MTWD—
0.00TWD—
0.00TWD—
0.00TWD—
Access this data via the Eulerpool API
Get Free API Key

Lin Bioscience Stock analysis

What does Lin Bioscience do? Lin Bioscience is one of the most popular companies on Eulerpool.

Debt Details

Understanding Lin Bioscience's Debt Structure

Lin Bioscience's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Lin Bioscience's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Lin Bioscience’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Lin Bioscience’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Lin Bioscience stock

Debt of Lin Bioscience is 33.99 M TWD in 2024.

Debt of Lin Bioscience changed from 42.87 M TWD to 33.99 M TWD, representing a -20.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Lin Bioscience since 2006 – with annual values, charts, and detailed analysis.

Debt's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Lin Bioscience historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Lin Bioscience

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Lin Bioscience